2022 Patient Support/Hub Provider Directory

Publication
Article
Pharmaceutical CommercePharmaceutical Commerce - April 2022
Volume 17
Issue 2

Download the 2022 Patient Support/Hub Provider Directory.
Download Issue PDF
Articles in this issue
2022 Patient Support Vendor Directory
2022 Patient Support Vendor Directory
Pharmaceutical Commerce - April 2022 Issue (PDF)
Pharmaceutical Commerce - April 2022 Issue (PDF)
Diving in Headfirst
Diving in Headfirst
Oncology Innovation: Optimism & Obstacles
Oncology Innovation: Optimism & Obstacles
The Pulse of Rare Disease Support
The Pulse of Rare Disease Support
Patient Centricity: Banishing Buzzwords
Patient Centricity: Banishing Buzzwords
Adding Might to ‘Specialty Lite’
Adding Might to ‘Specialty Lite’
Success with SP Solutions
Success with SP Solutions
Hub Programs from Patient Perspective
Hub Programs from Patient Perspective
Patient Support in Europe
Patient Support in Europe
Beyond Payment Methods
Beyond Payment Methods
Empowering Patients in Oncology Trials
Empowering Patients in Oncology Trials
Going with the Phlow
Going with the Phlow
Shedding the Secondary Label
Shedding the Secondary Label
2022 Patient Support/Hub Provider Directory
2022 Patient Support/Hub Provider Directory
Recent Videos
Related Content
Treating Rheumatoid Arthritis Patients With Biosimilars Versus Leflunomide: An Economic Evaluation

Treating Rheumatoid Arthritis Patients With Biosimilars Versus Leflunomide: An Economic Evaluation

Nicholas Saraceno, Editor
July 15th 2024
Article

A study explores the cost-effectiveness of combining methotrexate with various drugs as a way to combat failed methotrexate monotherapy.

A Further Examination of Pharmacy Benefit Managers

A Further Examination of Pharmacy Benefit Managers

Nicholas Saraceno, Editor
March 29th 2024
Podcast

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

Determining Drug Development Costs in the United States

Determining Drug Development Costs in the United States

Nicholas Saraceno, Editor
July 9th 2024
Article

An economic evaluation study assesses these costs by therapeutic class, while identifying trends in pharma R&D intensity over time.

Comparing Bariatric Metabolic Surgery, Glucagon-Like Peptide-1 Receptor Agonists Mortality Among Patients with Obesity and Diabetes

Comparing Bariatric Metabolic Surgery, Glucagon-Like Peptide-1 Receptor Agonists Mortality Among Patients with Obesity and Diabetes

Nicholas Saraceno, Editor
July 5th 2024
Article

An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.

Analyzing the Effects of Respiratory Syncytial Virus Pre- and Post-Pandemic

Analyzing the Effects of Respiratory Syncytial Virus Pre- and Post-Pandemic

Nicholas Saraceno, Editor
July 2nd 2024
Article

A cross-sectional study evaluates the difference in clinical outcomes and demographics between pediatric RSV patients during these multiple timeframes.

Barriers Encountered by Patients While Making Cancer Care Clinic Appointments

Barriers Encountered by Patients While Making Cancer Care Clinic Appointments

Nicholas Saraceno, Editor
June 28th 2024
Article

A cross-sectional audit study determines how racial and ethnic disparities—among English, Mandarin, and Spanish-speaking patients—can impact access.

© 2024 MJH Life Sciences

All rights reserved.